Evidence map›Paper›PMID 38812525›Full record

ArticleRespiratory medicine case reports2024

Two cases of airway-centered fibroelastosis treated with an antifibrotic agent and corticosteroids.

Miwa Kamatani, Minoru Inomata, Akari Misumi, Ken Ito, Takashi Maeda, Haruka Chin, Yu Ito, Keita Sakamoto, Nobuyasu Awano, Naoyuki Kuse and 5 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Respiratory medicine case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Miwa KamataniDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Minoru InomataDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Akari MisumiDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Ken ItoDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Takashi MaedaDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Haruka ChinDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Yu ItoDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Keita SakamotoDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Nobuyasu AwanoDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Naoyuki KuseDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.
Yoshiaki FuruhataDepartment of Respiratory Surgery, Japanese Red Cross Medical Center, Japan.
Yuan BaeDepartment of Pathology, Japanese Red Cross Medical Center, Japan.
Hiroaki SugiuraDepartment of Radiology, National Defense Medical College Hospital, Japan.
Tamiko TakemuraDepartment of Pathology, Kanagawa Cardiovascular and Respiratory Center, Japan.
Takehiro IzumoDepartment of Respiratory Medicine, Japanese Red Cross Medical Center, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Airway-centered fibroelastosis is characterized by peribronchovascular fibroelastosis, predominantly in the upper lobes, with little-to-no pleural involvement. In this study, we describe two cases of airway-centered fibroelastosis diagnosed based on radiological and pathological findings. The first case comprised a 44-year-old man whose forced vital capacity improved over three months following treatment with nintedanib. The second case involved a 50-year-old woman who was treated with oral corticosteroids but yielded an unfavorable outcome. An effective treatment for airway-centered fibroelastosis has not yet been identified; therefore, this study may help contribute to a more thorough discussion regarding treatment strategies for this disease.

Indexed as

Airway-centered fibroelastosisCorticosteroidsNintedanibPleuroparenchymal fibroelastosisProgressive fibrosing interstitial lung disease

Identifiers

PMID38812525
PMCPMC11135035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.